Products & Services · Total revenues
Adcirca — Total revenues
United Therapeutics Adcirca — Total revenues decreased by 62.8% to $2.90M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 51.7%, from $6.00M to $2.90M. Over 4 years (FY 2021 to FY 2025), Adcirca — Total revenues shows a downward trend with a -14.4% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementSegment
CategoryGrowth
SignalHigher is better
VolatilityModerate
First reportedQ4 2017
Last reportedQ1 2026
Rolls up toTotal Revenue
How to read this metric
An increase indicates growing market adoption or higher pricing power for the product, while a decrease suggests declining demand or competitive pressure.
Detailed definition
Represents the total gross revenue generated from the sale of a specific pharmaceutical product or therapeutic line. Thi...
Peer comparison
Standard revenue reporting for specific drug products in the pharmaceutical industry.
Metric ID:
uthr_segment_adcirca_total_revenuesHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $23.60M | $14.60M | $8.10M | $9.80M | $10.40M | $10.70M | $10.40M | $7.30M | $7.50M | $7.30M | $6.80M | $6.40M | $5.70M | $7.00M | $4.70M | $6.00M | $6.50M | $9.70M | $7.80M | $2.90M |
| QoQ Change | — | -38.1% | -44.5% | +21.0% | +6.1% | +2.9% | -2.8% | -29.8% | +2.7% | -2.7% | -6.8% | -5.9% | -10.9% | +22.8% | -32.9% | +27.7% | +8.3% | +49.2% | -19.6% | -62.8% |
| YoY Change | — | — | — | — | -55.9% | -26.7% | +28.4% | -25.5% | -27.9% | -31.8% | -34.6% | -12.3% | -24.0% | -4.1% | -30.9% | -6.3% | +14.0% | +38.6% | +66.0% | -51.7% |
Range$2.90M – $23.60M
CAGR-35.7%
Avg YoY Growth-11.5%
Median YoY Growth-24.8%
Current Streak2 quarters decline
Similar Metrics at Other Companies
Frequently Asked Questions
- What is United Therapeutics's adcirca — total revenues?
- United Therapeutics (UTHR) reported adcirca — total revenues of $2.90M in Q1 2026.
- How has United Therapeutics's adcirca — total revenues changed year-over-year?
- United Therapeutics's adcirca — total revenues decreased by 51.7% year-over-year, from $6.00M to $2.90M.
- What is the long-term trend for United Therapeutics's adcirca — total revenues?
- Over 4 years (2021 to 2025), United Therapeutics's adcirca — total revenues has grown at a -14.4% compound annual growth rate (CAGR), from $55.90M to $30.00M.
- What does adcirca — total revenues mean?
- The total sales revenue generated by a specific product line.